Cepi and AstraZeneca partner to manufacture 300 million coronavirus vaccines

The Coalition for Epidemic Preparedness Innovations (Cepi) has agreed a deal with AstraZeneca which will support the manufacture of 300 million globally accessible doses of the coronavirus vaccine candidate being trialled in the UK.